Preprint · OA
via OpenAlex
Aging-associated remodeling of ionic currents in ventricular myocytes of seasonal fish Nothobranchius furzeri
Tatiana S. Filatova, Irina Dzhumaniiazova, A. V. Shamshura, Абрамочкин Денис Валерьевич
Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · 2026
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.cbpa.2026.112013
- Canonical
- link ↗
- Fetched
- 2026-11-03 MST
Cite this
APA
Filatova, T.S., Dzhumaniiazova, I., Shamshura, A.V., & Валерьевич, �.�. (2026). Aging-associated remodeling of ionic currents in ventricular myocytes of seasonal fish Nothobranchius furzeri. <em>Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology</em>. https://doi.org/10.1016/j.cbpa.2026.112013
Vancouver
Filatova TS, Dzhumaniiazova I, Shamshura AV, Валерьевич ��. Aging-associated remodeling of ionic currents in ventricular myocytes of seasonal fish Nothobranchius furzeri. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 2026. doi:10.1016/j.cbpa.2026.112013.
BibTeX
@unpublished{tatiana2026Aginga,
title = {Aging-associated remodeling of ionic currents in ventricular myocytes of seasonal fish Nothobranchius furzeri},
author = {Tatiana S. Filatova and Irina Dzhumaniiazova and A. V. Shamshura and Абрамочкин Денис Валерьевич},
journal = {Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology},
year = {2026},
doi = {10.1016/j.cbpa.2026.112013},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ophthotech Corporation 2008
Open access · US-GOV
A Phase 1 Ascending Dose And Parallel Group Trial To Establish The Safety, Tolerability And Pharmacokinetic Profile of Multiple Intravitreous Injections of ARC1905 (Anti-C5 Aptamer) Given In Combination With Multiple Doses of Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration
Ophthotech Corporation 2007
Open access · US-GOV
A Phase 1, Single Ascending Dose Trial to Establish the Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) Monotherapy and of E10030 Given in Combination With Lucentis®0.5 Mg/Eye in Subjects With Neovascular Age-Related Macular Degeneration
Alcon Research 2013
Open access · US-GOV
A Multi-Center, Open-Label, Single Ascending Dose Study To Assess the Safety, Tolerability, and Serum Pharmacokinetics of Intravitreal CLG561 in Subjects With Advanced Age-Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 2018
Open access · US-GOV
FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment
Archives of Ophthalmology 1994
Citation only
Are Antioxidants or Supplements Protective for Age-Related Macular Degeneration?
Peking University 2010
Open access · US-GOV